Browse > Article

The effect of Valproic acid - Carbapenem antibiotics Interaction on Pharmacokinetics of Valproic acid and Seizure Development  

Seo, Hee Nam (Department of Pharmacy, Kangbuk Samsung Hospital)
Publication Information
Korean Journal of Clinical Pharmacy / v.22, no.3, 2012 , pp. 234-238 More about this Journal
Abstract
Background: Valproic acid is widely used in the treatment of generalized tonic-clonic and partial seizures. The carbapenem class is the most potent and widest spectrum of antimicrobial activity. Concomitant administration of carbapenems and valproic acid has been reported to decrease the serum concentration of valproic acid, which is sometimes associated with seizures. The purpose of this study is to evaluate the changes in valproic acid concentration and half life and the frequency of seizure during concomitant administration of valproic acid and carbapenems. Method: This study was performed retrospectively on total 40 cases with identified valproic acid concentration during concomitant administration of valproic acid and carbapenems at Kangbuk Samsung Hospital from February 1st, 2006 to October 31st, 2011. Patients were classified into 3 groups: ertapenem group (n=14), imipenem group (n=12), meropenem group (n=14). Results: The mean serum concentrations in each group during combined treatment were $9.50{\pm}8.84$, $21.88{\pm}8.17$ and $10.62{\pm}8.67$ mg/L, respectively (p < 0.001). The mean half-lives in each group during concurrent use of valproic acid and carbapenems were $3.18{\pm}0.81$, $4.63{\pm}1.97$ and $2.67{\pm}1.69$ hr, respectively (p < 0.001). The valproic acid serum concentration decreased by 75.5%, 54.1% and 84.1% and the half-life of valporoic acid decreased by 65.6%, 35.7% and 73.5%, respectively. Total cases with seizure were 12(30%) with 5(35.7%) in the ertapenem group, 3 (25.0%) in the imipenem group and 4(28.6%) in the meropenem group (p=0.911). There were no specific factors to influence on seizure development during combined treatment. Conclusion: Concurrent use of carbapenems and valproic acid should be avoided. If concomitant administration is essential, very close serum concentration monitoring and clinical observation are necessary.
Keywords
valproic acid; carbapenems; ertapenem; imipenem; meropenem; drug interaction; seizure;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Lunde JL, Nelson RE, Storandt HF. Acute seizures in a patient receiving divalproex sodium after starting ertapenem therapy. Pharmacotherapy. 2007 Aug; 27(8): 1202-1205.   DOI   ScienceOn
2 Hellwig TR, Onisk ML, Chapman BA. Potential interaction between valproic acid and doripenem. Curr Drug Saf. 2011 Feb 1; 6(1): 54-58.   DOI   ScienceOn
3 Young Sook Lee, Hyun Taek Shin. Retrospective Drug Utilization Review of Drug-Drug Interaction Criteria Based on Real World Data: Analysis in Terms of Dispensing Types. Kor. J. Clin. Pharm. 2011; 21(3): 249-255.
4 So jeong Yoon, Si hyun Park, Hye young Sin.Prescription Analysis after Operation of Incompatible Drug Screening Program. J. Kor. Soc. Health-Syst. Pharm.2005; 22(3): 238-244.
5 VillemureJ, de Tribolet N. Epilepsy in patients with central nervous system tumors. Curr Opin Neurol 1996; 9: 424-428.   DOI   ScienceOn
6 Van Breemen MSM, Vecht CJ. Optimal seizure management in brain tumor patients. Curr Neurol Nerosci Rep 2005; 5: 207-213.   DOI   ScienceOn
7 Isaac E. Silverman, MD; Lucas Restrepo, MD; Gregory C. Mathews, MD, PhD. Poststroke Seizures. Arch Neurol. 2002; 59: 195-201.   DOI   ScienceOn
8 Hauser W, Annegers J, Kurland L. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia. 1993; 34: 453-468.   DOI   ScienceOn
9 Bladin C, Alexandrov A, Bellavance A, et al., Seizures after stroke: a prospective multicenter study. Arch Neurol. 2000; 57: 1617-1622.   DOI   ScienceOn
10 Delanty N, Vaughan CJ, French JA. Medical causes of seizures. Lancet. 1998 Aug 1; 352(9125): 383-390.   DOI   ScienceOn
11 Soo Jin Kim, Sung Cil Lim, Bang Yeon Hwang, Chong Kil Lee, Jun Seop Lee,Sun Young Park, Song Yi Han, Myung Koo Lee. Drug Use Evaluation of Carbapenem in Korean Hospitalized Patients. Kor. J. Clin. Pharm.2007; 17(2): 109-116.
12 Nagai K, Shimizu T, Togo A,et al. Decrease in serum levels of valproic acid during treatment with a new carbapenem, panipenem/betamipron. J Antimicrob Chemother. 1997 Feb; 39(2): 295-296.   DOI   ScienceOn
13 Lee SG, Kim JH, Joo JY, Kwon OH. Seven cases of decreased serum valproic acid concentration during concomitant use of carbapenem antibiotics. Korean J Lab Med. 2007; 27: 338-343.   DOI
14 Coves-Orts FJ, Borras-Blasco J, Navarro-Ruiz A, Murcia- Lopez A, Palacios-Ortega F. Acute seizures due to a probable interaction between valproic acid and meropenem. Ann Pharmacother. 2005 Mar; 39(3): 533-537. Epub 2005 Feb 8.   DOI   ScienceOn
15 Spriet I, Goyens J, Meersseman W, Wilmer A, Willems L, Van Paesschen W. Interaction between valproate and meropenem: a retrospective study. Ann Pharmacother. 2007 Jul; 41(7): 1130-1136. Epub 2007 Jul 3.   DOI   ScienceOn
16 Liao FF, Huang YB, Chen CY.Decrease in serum valproic acid levels during treatment with ertapenem. Am J Health Syst Pharm. 2010 Aug; 67(15): 1260-1264.   DOI   ScienceOn